Rankings
▼
Calendar
BLTE FY 2022 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena
BLTE
Belite Bio, Inc
$7B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-0.63
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$12M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$44M
Total Liabilities
$3M
Stockholders' Equity
$42M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$13M
-$10M
-30.9%
Net Income
-$13M
-$10M
-30.9%
← Q4 2021
All Quarters
Q1 2022 →